Cargando…
Proteomics and network pharmacology of Ganshu Nuodan capsules in the prevention of alcoholic liver disease
INTRODUCTION: Ganshu Nuodan is a liver-protecting dietary supplement composed of Ganoderma lucidum (G. lucidum) spore powder, Pueraria montana (Lour.) Merr. (P. montana), Salvia miltiorrhiza Bunge (S. miltiorrhiza) and Astragalus membranaceus (Fisch.) Bunge. (A. membranaceus). However, its pharmacod...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10547213/ https://www.ncbi.nlm.nih.gov/pubmed/37795374 http://dx.doi.org/10.3389/fendo.2023.1229777 |
_version_ | 1785115013535498240 |
---|---|
author | Yang, Xiaonan Wang, Lei Cui, Xuejie Zhang, Jing Liang, Ying Luo, Zhaojing Zhou, Bingxue Jiang, Zheng Yang, Rachel Y. H. Wu, Yi Wei, Kunhua Du, Maobo Qin, Shuangshuang Dai, Chen Zhao, Guoliang |
author_facet | Yang, Xiaonan Wang, Lei Cui, Xuejie Zhang, Jing Liang, Ying Luo, Zhaojing Zhou, Bingxue Jiang, Zheng Yang, Rachel Y. H. Wu, Yi Wei, Kunhua Du, Maobo Qin, Shuangshuang Dai, Chen Zhao, Guoliang |
author_sort | Yang, Xiaonan |
collection | PubMed |
description | INTRODUCTION: Ganshu Nuodan is a liver-protecting dietary supplement composed of Ganoderma lucidum (G. lucidum) spore powder, Pueraria montana (Lour.) Merr. (P. montana), Salvia miltiorrhiza Bunge (S. miltiorrhiza) and Astragalus membranaceus (Fisch.) Bunge. (A. membranaceus). However, its pharmacodynamic material basis and mechanism of action remain unknown. METHODS: A mouse model of acute alcohol liver disease (ALD) induced by intragastric administration of 50% alcohol was used to evaluate the hepatoprotective effect of Ganshu Nuodan. The chemical constituents of Ganshu Nuodan were comprehensively identified by UPLC-QTOF/MS, and then its pharmacodynamic material basis and potential mechanism of action were explored by proteomics and network pharmacology. RESULTS: Ganshu Nuodan could ameliorate acute ALD, which is mainly manifested in the significant reduction of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) in serum and malondialdehyde (MDA) content in liver and the remarkably increase of glutathione (GSH) content and superoxide dismutase (SOD) activity in liver. Totally 76 chemical constituents were identified from Ganshu Nuodan by UPLC-QTOF/MS, including 21 quinones, 18 flavonoids, 11 organic acids, 7 terpenoids, 5 ketones, 4 sterols, 3 coumarins and 7 others. Three key signaling pathways were identified via proteomics studies, namely Arachidonic acid metabolism, Retinol metabolism, and HIF-1 signaling pathway respectively. Combined with network pharmacology and molecular docking, six key targets were subsequently obtained, including Ephx2, Lta4h, Map2k1, Stat3, Mtor and Dgat1. Finally, these six key targets and their related components were verified by molecular docking, which could explain the material basis of the hepatoprotective effect of Ganshu Nuodan. CONCLUSION: Ganshu Nuodan can protect acute alcohol-induced liver injury in mice by inhibiting oxidative stress, lipid accumulation and apoptosis. Our study provides a scientific basis for the hepatoprotective effect of Ganshu Nuodan in acute ALD mice and supports its traditional application. |
format | Online Article Text |
id | pubmed-10547213 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-105472132023-10-04 Proteomics and network pharmacology of Ganshu Nuodan capsules in the prevention of alcoholic liver disease Yang, Xiaonan Wang, Lei Cui, Xuejie Zhang, Jing Liang, Ying Luo, Zhaojing Zhou, Bingxue Jiang, Zheng Yang, Rachel Y. H. Wu, Yi Wei, Kunhua Du, Maobo Qin, Shuangshuang Dai, Chen Zhao, Guoliang Front Endocrinol (Lausanne) Endocrinology INTRODUCTION: Ganshu Nuodan is a liver-protecting dietary supplement composed of Ganoderma lucidum (G. lucidum) spore powder, Pueraria montana (Lour.) Merr. (P. montana), Salvia miltiorrhiza Bunge (S. miltiorrhiza) and Astragalus membranaceus (Fisch.) Bunge. (A. membranaceus). However, its pharmacodynamic material basis and mechanism of action remain unknown. METHODS: A mouse model of acute alcohol liver disease (ALD) induced by intragastric administration of 50% alcohol was used to evaluate the hepatoprotective effect of Ganshu Nuodan. The chemical constituents of Ganshu Nuodan were comprehensively identified by UPLC-QTOF/MS, and then its pharmacodynamic material basis and potential mechanism of action were explored by proteomics and network pharmacology. RESULTS: Ganshu Nuodan could ameliorate acute ALD, which is mainly manifested in the significant reduction of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) in serum and malondialdehyde (MDA) content in liver and the remarkably increase of glutathione (GSH) content and superoxide dismutase (SOD) activity in liver. Totally 76 chemical constituents were identified from Ganshu Nuodan by UPLC-QTOF/MS, including 21 quinones, 18 flavonoids, 11 organic acids, 7 terpenoids, 5 ketones, 4 sterols, 3 coumarins and 7 others. Three key signaling pathways were identified via proteomics studies, namely Arachidonic acid metabolism, Retinol metabolism, and HIF-1 signaling pathway respectively. Combined with network pharmacology and molecular docking, six key targets were subsequently obtained, including Ephx2, Lta4h, Map2k1, Stat3, Mtor and Dgat1. Finally, these six key targets and their related components were verified by molecular docking, which could explain the material basis of the hepatoprotective effect of Ganshu Nuodan. CONCLUSION: Ganshu Nuodan can protect acute alcohol-induced liver injury in mice by inhibiting oxidative stress, lipid accumulation and apoptosis. Our study provides a scientific basis for the hepatoprotective effect of Ganshu Nuodan in acute ALD mice and supports its traditional application. Frontiers Media S.A. 2023-09-18 /pmc/articles/PMC10547213/ /pubmed/37795374 http://dx.doi.org/10.3389/fendo.2023.1229777 Text en Copyright © 2023 Yang, Wang, Cui, Zhang, Liang, Luo, Zhou, Jiang, Yang, Wu, Wei, Du, Qin, Dai and Zhao https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Endocrinology Yang, Xiaonan Wang, Lei Cui, Xuejie Zhang, Jing Liang, Ying Luo, Zhaojing Zhou, Bingxue Jiang, Zheng Yang, Rachel Y. H. Wu, Yi Wei, Kunhua Du, Maobo Qin, Shuangshuang Dai, Chen Zhao, Guoliang Proteomics and network pharmacology of Ganshu Nuodan capsules in the prevention of alcoholic liver disease |
title | Proteomics and network pharmacology of Ganshu Nuodan capsules in the prevention of alcoholic liver disease |
title_full | Proteomics and network pharmacology of Ganshu Nuodan capsules in the prevention of alcoholic liver disease |
title_fullStr | Proteomics and network pharmacology of Ganshu Nuodan capsules in the prevention of alcoholic liver disease |
title_full_unstemmed | Proteomics and network pharmacology of Ganshu Nuodan capsules in the prevention of alcoholic liver disease |
title_short | Proteomics and network pharmacology of Ganshu Nuodan capsules in the prevention of alcoholic liver disease |
title_sort | proteomics and network pharmacology of ganshu nuodan capsules in the prevention of alcoholic liver disease |
topic | Endocrinology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10547213/ https://www.ncbi.nlm.nih.gov/pubmed/37795374 http://dx.doi.org/10.3389/fendo.2023.1229777 |
work_keys_str_mv | AT yangxiaonan proteomicsandnetworkpharmacologyofganshunuodancapsulesinthepreventionofalcoholicliverdisease AT wanglei proteomicsandnetworkpharmacologyofganshunuodancapsulesinthepreventionofalcoholicliverdisease AT cuixuejie proteomicsandnetworkpharmacologyofganshunuodancapsulesinthepreventionofalcoholicliverdisease AT zhangjing proteomicsandnetworkpharmacologyofganshunuodancapsulesinthepreventionofalcoholicliverdisease AT liangying proteomicsandnetworkpharmacologyofganshunuodancapsulesinthepreventionofalcoholicliverdisease AT luozhaojing proteomicsandnetworkpharmacologyofganshunuodancapsulesinthepreventionofalcoholicliverdisease AT zhoubingxue proteomicsandnetworkpharmacologyofganshunuodancapsulesinthepreventionofalcoholicliverdisease AT jiangzheng proteomicsandnetworkpharmacologyofganshunuodancapsulesinthepreventionofalcoholicliverdisease AT yangrachelyh proteomicsandnetworkpharmacologyofganshunuodancapsulesinthepreventionofalcoholicliverdisease AT wuyi proteomicsandnetworkpharmacologyofganshunuodancapsulesinthepreventionofalcoholicliverdisease AT weikunhua proteomicsandnetworkpharmacologyofganshunuodancapsulesinthepreventionofalcoholicliverdisease AT dumaobo proteomicsandnetworkpharmacologyofganshunuodancapsulesinthepreventionofalcoholicliverdisease AT qinshuangshuang proteomicsandnetworkpharmacologyofganshunuodancapsulesinthepreventionofalcoholicliverdisease AT daichen proteomicsandnetworkpharmacologyofganshunuodancapsulesinthepreventionofalcoholicliverdisease AT zhaoguoliang proteomicsandnetworkpharmacologyofganshunuodancapsulesinthepreventionofalcoholicliverdisease |